Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Allergin is a traditional Ayurvedic herbal formulation developed and manufactured by Nagarjuna Herbal Concentrates. It is primarily marketed in a granule form ("Allergin Granules") and is indicated for the management of various allergic conditions, including respiratory issues such as cough, cold, and allergic rhinitis, as well as skin disorders like urticaria and pruritus. As an Ayurvedic proprietary medicine, it contains a blend of traditional botanical extracts intended to modulate the immune response and provide symptomatic relief from inflammatory reactions associated with allergens. It is sold as an over-the-counter (OTC) consumer product and does not have a defined molecular target or standard clinical development phases (Phase 1-3) typical of modern synthetic pharmaceuticals.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Allergin.